Qventus

Prediction and automated action are the product, not reporting. The company states the platform goes beyond making optimization recommendations, using AI and behavioral science with hyper localized data to predict barriers, optimize decisions, and take action on behalf of the care team. The distinction from analytics dashboards, which is what most operational software in hospitals actually is, is that the system executes the next step rather than surfacing a chart about it.

The AI Operational Assistants act autonomously on administrative coordination work, described as speaking, hearing, reading, gathering, understanding, and writing to anticipate next steps and take action. The safety boundary is that the work is operational rather than clinical: discharge planning coordination, ancillary order prioritization, fax processing, and pre admission testing follow up. Clinical judgment stays with the care team. What is not published is the escalation logic when an assistant's action is wrong, which for discharge planning has real patient impact.

Technique is named at a general level, generative AI plus machine learning plus behavioral science, with one meaningful architectural claim: the company states its platform is trained on each customer's own data and tuned to their processes rather than deploying generic models producing one size fits most guidance. That is a real design position with cost and performance implications. No model provider, validation methodology, or performance characteristics are published.

The strongest operational evidence in this category tier. Multi year results are published at named institutions with specific figures: a three year HonorHealth inpatient deployment reporting 86 percent of patients receiving early discharge plans, more than 50,000 excess days saved, and 62 million dollars in savings; OhioHealth reporting nearly 1,400 excess days and roughly half a million dollars within the first month; Northwestern Medicine unlocking over 1,300 operating room hours monthly at a stated 15x annualized ROI. Aggregate 2025 figures across clients are also disclosed. Buyers should note these are vendor reported rather than independently audited, and that discharge acceleration metrics deserve scrutiny for readmission effects, which are not addressed in the published figures.

No published AI safety framework or PHI handling disclosure was located on the company's own materials. The platform is deeply integrated with the EHR and acts on live patient flow data, so the PHI surface is substantial. Third party vendor comparisons assert HIPAA compliance and BAA availability as table stakes for this category, but that is not a vendor published commitment and a buyer should verify directly.

No HIPAA or BAA statement was located in the company's own published materials. Given the customer base is United States health systems and the platform processes patient level data inside the EHR, a BAA is almost certainly in place contractually, but the index grades what is published rather than what is presumed.

No SOC 2, HITRUST, or ISO 27001 attestation was located in vendor published materials, and no trust center was found. For a platform embedded in hospital EHRs at this scale, publishing certification status would be a low cost improvement to buyer diligence.

No FDA pathway applies and none is claimed. The platform automates operational and administrative coordination rather than informing diagnosis or treatment selection, which keeps it outside Software as a Medical Device. The discharge planning products sit closest to the boundary, since predicted discharge dates influence care decisions, but the outputs are operational forecasts rather than clinical recommendations.

No AI governance framework or bias evaluation was located. This matters more than it first appears in operational AI: models that predict discharge readiness and prioritize ancillary resources allocate scarce hospital capacity, and systematic bias in those predictions would distribute care access unevenly without ever appearing as a clinical decision. Nothing published addresses whether that is monitored.

EHR integration is the delivery mechanism rather than a feature. The company states the platform is deeply integrated with the EHR, pulling together multiple data streams and acting inside it, and describes the inpatient solution as seamlessly embedded in the EHR where it populates expected discharge dates and dispositions by the first morning after admission. Writing structured clinical workflow data back into the chart is a materially higher integration bar than reading data out, and the customer base of large academic medical centers implies Epic depth in practice.

No hosting, tenancy, or data residency disclosure was located. The stated approach of training on each customer's own data raises a question a buyer should ask directly, which is whether model artifacts derived from one health system's data are isolated from other customers.

No published pricing. Third party analysis notes the company quotes custom contracts scoped to a health system, which is the norm for enterprise hospital operations platforms. The ROI figures the company publishes are unusually specific, which partially compensates by letting a buyer model value even without price, but the cost side remains entirely opaque until sales contact.

Coverage is deliberately scoped to acute care operations: perioperative care coordination, surgical growth and operating room utilization, and inpatient capacity and discharge. Earlier materials also reference emergency department and command center settings. Named customers span academic medical centers, community hospitals, and multi hospital systems. Ambulatory, post acute, and payer settings are outside scope, and the AI Solution Factory is the stated path to workflows beyond the core three.